肿瘤相关巨噬细胞通过激活IGF-1R信号通路诱导三阴性乳腺癌细胞对白蛋白紫杉醇耐药的研究

doi:10.11958/20230438

天津医药 ›› 2023, Vol. 51 ›› Issue (11): 1158-1163.doi: 10.11958/20230438

肿瘤相关巨噬细胞通过激活IGF-1R信号通路诱导三阴性乳腺癌细胞对白蛋白紫杉醇耐药的研究

刘淑娟¹^,²(), 刘梦莹¹, 苏乌云³, 窦佳³, 王薇³^,^△()

1.内蒙古医科大学第一临床医学院（邮编010059）
2.内蒙古阿荣旗人民医院内科
3.内蒙古医科大学附属医院肿瘤内科

收稿日期:2023-03-27 修回日期:2023-05-23 出版日期:2023-11-15 发布日期:2023-11-07
通讯作者: ^△E-mail：656225284@qq.com
作者简介:刘淑娟（1984），女，硕士在读，主要从事肿瘤诊治及机制方面研究。E-mail：33562569@qq.com
基金资助:
北京科创医学发展基金会项目(KC2021-JX-0044-9);内蒙古自治区卫生健康科技计划项目(202202191)

Investigation on the determination of tumor-associated macrophages inducing the drug resistance of albumin-bound paclitaxel in triple-negative breast cancer cells by activating IGF-1R signaling pathway

LIU Shujuan¹^,²(), LIU Mengying¹, SU Wuyun³, DOU Jia³, WANG Wei³^,^△()

1. The First Clinical College of Inner Mongolia Medical University, Hohhot 010059, China
2. Department of Internal Medicine, Inner Mongolia A Rong Qi People's Hospital
3. Department of Oncology, Affiliated Hospital of Inner Mongolia Medical University

Received:2023-03-27 Revised:2023-05-23 Published:2023-11-15 Online:2023-11-07
Contact: ^△E-mail：656225284@qq.com

刘淑娟, 刘梦莹, 苏乌云, 窦佳, 王薇. 肿瘤相关巨噬细胞通过激活IGF-1R信号通路诱导三阴性乳腺癌细胞对白蛋白紫杉醇耐药的研究[J]. 天津医药, 2023, 51(11): 1158-1163.

LIU Shujuan, LIU Mengying, SU Wuyun, DOU Jia, WANG Wei. Investigation on the determination of tumor-associated macrophages inducing the drug resistance of albumin-bound paclitaxel in triple-negative breast cancer cells by activating IGF-1R signaling pathway[J]. Tianjin Medical Journal, 2023, 51(11): 1158-1163.

摘要/Abstract

摘要：

目的探讨肿瘤相关巨噬细胞（TAM）对三阴性乳腺癌（TNBC）细胞白蛋白紫杉醇（Nab-PTX）化疗敏感性的影响及作用机制。方法构建并鉴定TAM模型；通过Transwell小室共培养法建立TAM与TNBC细胞系MDA-MB-231细胞共培养模式，分为对照组（MDA-MB-231细胞及空白小室）、Nab-PTX组（MDA-MB-231细胞、空白小室及0.5 nmol/L Nab-PTX）、TAM组（MDA-MB-231细胞、含M2型巨噬细胞的小室）、TAM+Nab-PTX组（MDA-MB-231细胞、含M2型巨噬细胞的小室及0.5 nmol/L Nab-PTX）、胰岛素样生长因子1受体（IGF-1R）抑制剂组（MDA-MB-231细胞、含M2型巨噬细胞的小室、0.5 nmol/L Nab-PTX及4 nmol/L IGF-1R抑制剂Linsitinib）；CCK-8法检测各组细胞增殖情况；流式细胞术检测细胞凋亡；实时荧光定量PCR（qPCR）检测多药耐药蛋白（MDR）1和胱天蛋白酶（Caspase）-3 mRNA水平；Western blot检测IGF-1R信号通路关键蛋白表达。结果 THP-1细胞经诱导分化为M2型巨噬细胞；与Nab-PTX组相比，TAM+Nab-PTX组细胞增殖水平升高，凋亡率降低（P<0.01），MDR1 mRNA表达升高，Caspase-3 mRNA表达降低（P<0.05），IGF-1R信号通路关键蛋白激活（P<0.01）；与TAM+Nab-PTX组相比，IGF-1R抑制剂组细胞增殖水平降低，凋亡率升高，MDR1 mRNA表达降低，Caspase-3 mRNA的表达增高，IGF-1R信号通路关键蛋白的表达降低（P<0.01）。结论 TAM可能通过激活IGF-1R信号通路诱导TNBC细胞对Nab-PTX耐药。

Abstract:

Objective To investigate the effect of tumor-associated macrophages (TAM) on the chemosensitivity of triple-negative breast cancer (TNBC) cells to albumin-bound paclitaxel (Nab-PTX). Methods TAM model was constructed and identified. TNBC cell line MDA-MB-231 was established by Transwell cell co-culture method. They were divided into the control group (MDA-MB-231 cells and blank chamber), the Nab-PTX group (MDA-MB-231 cells, blank chamber and 0.5 nmol/L Nab-PTX), the TAM group (MDA-MB-231 cells, containing M2-type macrophages), the TAM+Nab-PTX group (MDA-MB-231 cells, cells containing M2-type macrophages and 0.5 nmol/L Nab-PTX) and the insulin-like growth factor 1 receptor (IGF-1R) inhibitor group (MD-MB-231 cells, macrophage compartment containing M2-type, 0.5 nmol/L Nab-PTX and 4 nmol/L IGF-1R inhibitor Linsitinib). The cell survival rate of each group was determined by CCK-8 method. Flow cytometry was used to detect cell apoptosis. The mRNA levels of multidrug resistant protein (MDR) 1 and Caspase-3 were detected by real-time quantitative PCR (qPCR). The key proteins of IGF-1R signaling pathway were detected by Western blot assay. Results THP-1 cells were induced to differentiate into M2 macrophages. Compared with the Nab-PTX group, the cell proliferation rate was increased and apoptosis rate was decreased in the TAM+Nab-PTX group (P<0.01). The mRNA expression of MDR1was increased and Caspase-3 mRNA was decreased (P<0.05). The key protein of IGF-1R signaling pathway was activated (P<0.01). Compared with the TAM+Nab-PTX group, the proliferation rate was decreased and apoptosis rate of cells was increased in the IGF-1R inhibitor group. The mRNA expression of MDR1 was decreased, the mRNA expression of Caspase3 was increased, and the expression of key proteins in IGF-1R signaling pathway was decreased (P<0.01). Conclusion TAM may induce resistance of TNBC cells to Nab-PTX by activating IGF-1R signaling pathway.

Key words: tumor-associated macrophages, triple negative breast neoplasms, albumin-bound paclitaxel, drug tolerance, receptor, IGF type 1

中图分类号:

R737.9

图/表 10

图1 TAM表面标志物CD14、CD206的表达特征

Fig.1 The characteristics of cell surface markers CD14 and CD206 in TAM

表1 4组MDA-MB-231细胞不同时间点增殖情况比较（n=3，OD490，$\bar{x}±s$）

Tab.1 Comparison of proliferation of MDA-MB-231 cells at different time points between four groups

组别	24 h	48 h	72 h
对照组	0.470±0.002	0.630±0.001	0.770±0.004
Nab-PTX组	0.440±0.002^a	0.540±0.004^a	0.620±0.003^a
TAM组	0.510±0.002^b	0.720±0.001^b	0.930±0.006^b
TAM+Nab-PTX组	0.460±0.002^b	0.610±0.003^b	0.760±0.006^b
F	716.879^＊＊	2 090.309^＊＊	2 276.647^＊＊

图2 TAM对Nab-PTX干预MDA-MB-231细胞凋亡的影响

Fig.2 Effects of TAM on apoptosis of MDA-MB-231 cells induced by Nab-PTX

表2 2组MDA-MB-231细胞不同时间点增殖情况比较（n=3，OD490，$\bar{x}±s$）

Tab.2 Comparison of proliferation of MDA-MB-231 cells at different time points between two groups

组别	24 h	48 h	72 h
TAM+Nab-PTX组	0.460±0.002	0.610±0.003	0.760±0.006
IGF-1R抑制剂组	0.420±0.001	0.500±0.003	0.560±0.003
t	19.290^＊＊	42.832^＊＊	45.987^＊＊

图3 IGF-1R抑制剂对TAM共培养MDA-MB-231细胞凋亡的影响

Fig.3 Effects of IGF-1R inhibitors on apoptosis of MDA-MB-231 cells co-cultured with TAM

表3 4组MDA-MB-231细胞MDR1和Caspase-3 mRNA表达的比较（n=3，$\bar{x}±s$）

Tab.3 Comparison of MDR1 mRNA and Caspase-3 mRNA expression between four groups of MDA-MB-231 cells

组别	MDR1	Caspase-3
对照组	1.00±0.03	1.00±0.02
Nab-PTX组	0.29±0.01^a	2.03±0.04^a
TAM组	1.72±0.61	0.58±0.40
TAM+Nab-PTX组	0.83±0.03^b	1.20±0.02^b
F	934.279^＊＊	21.360^＊＊

表4 各组MDA-MB-231细胞内p-IGF-1R、p-AKT、p-ERK蛋白表达水平比较（n=6，$\bar{x}±s$）

Tab.4 Comparison of protein expression levels of p-IGF-1R, p-AKT and p-ERK between MDA-MB-231 cells of each group

组别	p-IGF-1R/ IGF-1R	p-AKT/AKT	p-ERK/ERK
对照组	1.030±0.001	0.780±0.001	0.980±0.007
Nab-PTX组	0.400±0.002^a	0.460±0.003^a	0.570±0.002^a
TAM组	1.300±0.004^ab	0.960±0.002^ab	1.320±0.002^ab
TAM+Nab-PTX组	0.980±0.008^b	0.740±0.004^b	0.770±0.013^b
F	17 108.381^＊＊	13 656.675^＊＊	5 499.251^＊＊

图4 Western blot检测各组MDA-MB-231细胞内IGF-1R、p-IGF-1R、AKT、p-AKT、ERK、p-ERK蛋白表达

Fig.4 The protein expression levels of IGF-1R, p-IGF-1R, AKT, p-AKT, ERK and p-ERK in each group

表5 2组细胞内p-IGF-1R、p-AKT、p-ERK比较（n=6，$\bar{x}±s$）

Tab.5 Comparison of p-IGF-1R, p-AKT and p-ERK rations between the two groups of cells

组别	p-IGF-1R/IGF-1R	p-AKT/AKT	p-ERK/ERK
TAM+Nab-PTX组	1.280±0.014	1.120±0.020	0.860±0.006
IGF-1R抑制剂组	0.500±0.009	0.450±0.002	0.420±0.001
t	77.249^＊＊	57.151^＊＊	119.965^＊＊

图5 TAM+Nab-PTX组和IGF-1R抑制剂组蛋白表达印迹图

Fig.5 Western blot assay of the TAM+Nab-PTX group and the IGF-1R inhibitor group

参考文献 19

[1]	SINGH D D, YADAV D K. TNBC:Potential targeting of multiple receptors for a therapeutic breakthrough,nanomedicine,and immunotherapy[J]. Biomedicines, 2021, 9(8):876. doi:10.3390/biomedicines9080876.
[2]	成兴真, 杨芳, 王杨, 等. 白蛋白紫杉醇与五氟尿嘧啶联合用药对人胃癌细胞增殖及周期的影响[J]. 贵阳医学院学报, 2021, 46(11):1289-1293,1300.
	CHENG X Z, YANG F, WANG Y, et al. Effects of albumin-bound paclitaxel combined with 5-fluorouracil on proliferation and cycle of gastric cancer cells[J]. Journal of Guizhou Medical University, 2021, 46(11):1289-1293,1300. doi:10.1155/2022/6015877.
[3]	李颜君. 注射用白蛋白结合型紫杉醇与普通紫杉醇治疗转移性乳腺癌的近期疗效及安全性研究[J]. 中国实用医药, 2022, 17(7):161-164.
	LI Y J. Short-term efficacy and safety of albumin-bound paclitaxel for injection and conventional paclitaxel in the treatment of metastatic breast cancer[J]. China Practical Medical, 2022, 17(7):161-164. doi:10.14163/j.cnki.11-5547/r.2022.07.058.
[4]	BINNEMARS-POSTMA K, BANSAL R, STORM G, et al. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer[J]. FASEB J, 2018, 32(2):969-978. doi:10.1096/fj.201700629R.
[5]	LI D, JI H, NIU X, et al. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer[J]. Cancer Sci, 2020, 111(1):47-58. doi:10.1111/cas.14230.
[6]	WANG C, LIN Y, ZHU H, et al. The prognostic and clinical value of tumor-associated macrophages in patients with breast cancer:A systematic review and meta-analysis[J]. Front Oncol, 2022, 12:905846. doi:10.3389/fonc.2022.905846.
[7]	ZHANG Y, GAO C, CAO F, et al. Pan-cancer analysis of IGF-1 and IGF-1R as potential prognostic biomarkers and immunotherapy targets[J]. Front Oncol, 2021, 11:755341. doi:10.3389/fonc.2021.755341.
[8]	NGO M T, JENG H Y, KUO Y C, et al. The role of IGF/IGF-1R signaling in hepatocellular carcinomas:Stemness-related properties and drug resistance[J]. Int J Mol Sci, 2021, 22(4):1931. doi:10.3390/ijms22041931.
[9]	WEIWEI Z, YA X, WENWEN W, et al. IGF-1R anti-idiotypic antibody antagonist exhibited anti-ovarian cancer bioactivity and reduced cisplatin resistance[J]. Hum Cell, 2021, 34(4):1197-1214. doi:10.1007/s13577-021-00535-x.
[10]	周芷若. 消癌解毒方抗消化系肿瘤的效应及机制研究[D]. 南京: 南京中医药大学, 2016.
	ZHOU Z R. Study on the effect and mechanism of Xiaoaijiedu decoction on digestive system tumors[D]. Nanjing: Nanjing University of Chinese Medicine, 2016. doi:10.27253/d.cnki.gnjzu.2016.000032.
[11]	郑培明, 李俊蒙, 张鹏, 等. 巨噬细胞外泌体源miR-223促进胃癌细胞对奥沙利铂的耐药研究[J]. 中国癌症杂志, 2021, 31(5):368-376.
	ZHENG P M, LI J M, ZHANG P, et al. Exosomal transfer of macrophage-derived miR-223 confers oxaliplatin resistance in gastric cancer[J]. China Oncology, 2021, 31(5):368-376. doi:10.19401/j.cnki.1007-3639.2021.05.002.
[12]	戈文珂, 吴卫兵. 肿瘤微环境中肿瘤相关巨噬细胞极化的影响因素及其意义[J]. 中国肺癌杂志, 2023, 26(3):228-237.
	GE W K, WU W B. Influence factors and significance of tumor-associated macrophage polarization in tumor microenvironment[J]. Chinese Journal of Lung Cancer, 2023, 26(3):228-237.
[13]	YANG C, HE L, HE P, et al. Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway[J]. Med Oncol, 2015, 32(2):352. doi:10.1007/s12032-014-0352-6.
[14]	QIAO J, CHEN Y, MI Y, et al. Macrophages confer resistance to BET inhibition in triple-negative breast cancer by upregulating IKBKE[J]. Biochem Pharmacol, 2020, 180:114126. doi:10.1016/j.bcp.2020.114126.
[15]	GROGAN T M, SPIER C M, SALMON S E, et al. P-glycoprotein expression in human plasma cell myeloma:correlation with prior chemotherapy[J]. Blood, 1993, 81(2):490-495.
[16]	BASS-STRINGER S, OOI J, MCMULLEN J R. Clusterin is regulated by IGF1-PI3K signaling in the heart:implications for biomarker and drug target discovery,and cardiotoxicity[J]. Arch Toxicol, 2020, 94(5):1763-1768. doi:10.1007/s00204-020-02709-2.
[17]	IRELAND L, SANTOS A, CAMPBELL F, et al. Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer[J]. Oncogene, 2018, 37(15):2022-2036. doi:10.1038/s41388-017-0115-x.
[18]	DAVISON Z, DE BLACQUIÈRE G E, WESTLEY B R, et al. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells:implications for therapy[J]. Neoplasia, 2011, 13(6):504-515. doi:10.1593/neo.101590.
[19]	LIU S, CHEN S, YUAN W, et al. PD-1/PD-L1 interaction up-regulates MDR1/P-gp expression in breast cancer cells via PI3K/AKT and MAPK/ERK pathways[J]. Oncotarget, 2017, 8(59):99901-99912. doi:10.18632/oncotarget.21914.

肿瘤相关巨噬细胞通过激活IGF-1R信号通路诱导三阴性乳腺癌细胞对白蛋白紫杉醇耐药的研究

Investigation on the determination of tumor-associated macrophages inducing the drug resistance of albumin-bound paclitaxel in triple-negative breast cancer cells by activating IGF-1R signaling pathway

引用本文

RichHTML

PDF (PC)

可视化

摘要/Abstract

使用本文

图/表 10

参考文献 19

相关文章 15

编辑推荐

Metrics

本文评价

[1]	吴杰, 姬冰瑞, 郭瑞霞. 血清PDGF与子宫下段肌壁厚度对瘢痕子宫再次妊娠分娩结局的预测价值[J]. 天津医药, 2026, 54(7): 760-764.
[2]	刘甚红, 马媛媛, 张丽梅. IgE高亲和力受体结合NPC2对DNP-BSA诱导的肥大细胞脱颗粒和组胺释放的机制探讨[J]. 天津医药, 2026, 54(5): 455-461.
[3]	卢红霞, 郭燕军, 黄晗, 张婷. miR-421靶向MPP7/EGFR/AKT轴影响巨噬细胞M2极化改善哮喘小鼠的气道炎症[J]. 天津医药, 2026, 54(5): 462-468.
[4]	徐彤, 杨星旺, 刘永辉. Toll样受体激动剂及其在肿瘤疫苗中的应用研究进展[J]. 天津医药, 2026, 54(5): 550-555.
[5]	赵政委, 许文艳, 郭晓敏, 王敏, 李建丽, 李志海, 沈东琼, 涂云贵. 脓毒症患者血清LRG1、suPAR水平对并发急性肾损伤的预测价值[J]. 天津医药, 2026, 54(4): 374-378.
[6]	冯小艳, 张文倩, 方自红, 张广辉. NRP-1和CXCR4对卵巢子宫内膜异位囊肿患者妊娠结局的预测价值[J]. 天津医药, 2026, 54(4): 402-406.
[7]	姜天佑, 李敏, 孙碧文, 李越洋, 邢丽静, 田晨. Let-7b诱导白血病相关巨噬细胞复极抑制AML的发展[J]. 天津医药, 2026, 54(3): 225-231.
[8]	黄熷远, 付靖, 赵亚, 王龙灏, 仓顺东. 非小细胞肺癌EGFR-TKI耐药与p53基因突变的研究进展[J]. 天津医药, 2026, 54(3): 333-336.
[9]	黄慧琦, 伍秋苑, 张昆, 李佩贤, 熊亚明, 叶国麟, 周丹. 川楝素联合奥拉帕尼在三阴性乳腺癌中的抗肿瘤机制研究[J]. 天津医药, 2025, 53(9): 897-902.
[10]	万艳波, 刘明, 王勇. 秦皮甲素调节HMGB1/RAGE信号通路对缺氧/复氧诱导的心肌细胞损伤的影响[J]. 天津医药, 2025, 53(8): 796-801.
[11]	贾文歆, 周利娟, 王丽香. 血清CCL21、NLRP3与脑梗死患者机械取栓术后出血转化的相关性研究[J]. 天津医药, 2025, 53(7): 700-703.
[12]	吴素勤, 徐子舒, 许智晶, 吴洁, 王聪梅. 重症颅脑损伤减压术患者血清MMP-10、TLR2水平及其与疾病转归的关系[J]. 天津医药, 2025, 53(7): 704-708.
[13]	杜凌云, 王耀武, 任楠. 肾透明细胞癌中PRMT2、TRAF2与转移相关基因表达对预后的评估价值[J]. 天津医药, 2025, 53(5): 492-497.
[14]	邓海娟, 权永娟, 李芳. 妊娠期糖尿病患者血清GPER1、CFH水平与妊娠结局的关系[J]. 天津医药, 2025, 53(4): 369-373.
[15]	郑少阳, 智慧, 王曼, 武冰, 张清格, 李冠阳. 酒精性肝病患者外周血sTim-3、sST2水平与疾病严重程度的相关性[J]. 天津医药, 2025, 53(4): 383-388.